Stock OCTP OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Oxford Cannabinoid Technologies Holdings Plc

Equities

OCTP

GB00BMVMRB86

Market Closed - London S.E.
Other stock markets
 11:35:05 2024-05-03 am EDT 		5-day change 1st Jan Change
0.345 GBX -1.43% Intraday chart for Oxford Cannabinoid Technologies Holdings Plc -5.48% -44.80%
Apr. 11 Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment AN
Apr. 09 Oxford Cannabinoid Technologies Holdings plc Appoints Timothy Henry Corn as A Director CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oxford Cannabinoid Technologies strengthens board with CMO Dr. Tim Corn
AQ
Oxford Cannabinoid Technologies Holdings plc
AQ
Oxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trial
AQ
Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial
AQ
Oxford Cannabinoid Technologies in a "comfortable position" ahead of Phase 1 results release
AQ
Oxford Cannabinoid Technologies "officially on the way" after first dosing
AQ
Oxford Cannabinoid Technologies first dosing a "major achievement" - Proactive Research Analyst
AQ
Oxford Cannabinoid Technologies announces "potential breakthrough" in field of oncology
AQ
Oxford Cannabinoid Technologies: Phase 1 approval for lead chronic pain drug
AQ
Oxford Cannabinoid Technologies reaches milestone with phase 1 trial approval for pain relief drug
AQ
Oxford Cannabinoid Technologies confirms Sowemimo-Coker as permanent CEO
AQ
Proactive's John Savin publishes fresh research note on Oxford Cannabinoid Technologies
AQ
Oxford Cannabinoid Technologies with "lots to look forward to" after interims
AQ
Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting
AQ
Oxford Cannabinoid Technologies "ready to go" after phase 1 trial submission
AQ
Proactive research analyst John Savin on Oxford Cannabinoid Technologies
AQ
Proactive research analyst John Savin on Oxford Cannabinoid Technologies
EQ
Oxford Cannabinoid Technologies "very confident" heading into 2023
AQ
Oxford Cannabinoid Technologies 'very confident' heading into 2023
EQ
Oxford Cannabinoid Technologies appoints new CEO
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OCTP Stock
  4. News Oxford Cannabinoid Technologies Holdings Plc
  5. Press Releases